EchoPixel's True3D software enables heart teams to interact with medical images the way they would with physical objects in the real world. It leverages CT, MR, echocardiography and C-Arm fluoroscopy images to create life-size holographic versions of organs, blood vessels and other structures. This allows physicians to interact with a digital twin of the patient specific anatomy to identify the optimal treatment target, approach and catheter position, capturing accurate measurements, distances and angles. Delivering better visualization of anatomical structures and spatial relationships, True3D has been shown to facilitate completion of procedures with reproducible and reliable outcomes.

"Based on the complexity involved in many of the cutting-edge interventional procedures, such as Watchman and MitralClip, adoption has been largely concentrated at academic centers and large, high volume cardiology programs. By offering real-time, interactive mixed reality intraoperative anatomical imaging and planning capabilities, we hope to help smaller hospitals and cardiology programs adopt these cutting edge procedures and improve access to all patients," added Aguirre.

About EchoPixel
EchoPixel is building a new world of patient care with its groundbreaking medical visualization software. The company's FDA-cleared True3D Viewer uses existing medical image datasets to create virtual reality environments of patient-specific anatomy, allowing physicians to view and dissect images just as they would real, physical objects. The technology aims to make reading medical images more intuitive, help physicians reach diagnosis, and assist in surgical planning. Leading institutions, including the University of California, San Francisco, the Cleveland Clinic, the Lahey Clinic, and more are using True3D in clinical and research applications. EchoPixel is a privately held, venture backed company located in Santa Clara, Calif.


SOURCE EchoPixel

Back to HCB News

Cardiology Homepage